載入...
PI3K/Akt/mTOR inhibitors in breast cancer
Activation of the phosphoinositide 3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway is common in breast cancer. There is preclinical data to support inhibition of the pathway, and phase I to III trials involving inhibitors of the pathway have been or are being conducted in solid tumo...
Na minha lista:
| 發表在: | Cancer Biol Med |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Chinese Anti-Cancer Association
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4706528/ https://ncbi.nlm.nih.gov/pubmed/26779371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7497/j.issn.2095-3941.2015.0089 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|